EUVIMEDEUVIMED entdecken
Crossref

Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study

Min Tao iD, Guanghong Zhou, Jing Liu, Miao He, Cong Wang, Xie Luo, Lili Zhang iD

Clinical Endocrinology · 2023-10 · 99 (4) · 370-377

DOI: 10.1111/cen.14953 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology, online erschienen am 10.08.2023. Verfasst von Min Tao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Observational studies have shown that visceral adipose tissue (VAT) can increase the risk of nonalcoholic fatty liver disease (NAFLD). However, the causality of this association remains unclear. Therefore, this study aimed to explore the causal association between VAT and NAFLD.

Design

We obtained single‐nucleotide polymorphisms strongly associated with VAT ( n = 325,153) from large‐scale genome‐wide association studies. Summary‐level data for NAFLD (2275 cases and 375,002 controls) was available from the FinnGen consortium. We applied two‐sample Mendelian randomization (MR) to determine the causal association between VAT and NAFLD. The random‐effects inverse‐variance weighted (IVW) method was used as the main MR approach, with alternate methods including the weighted median (WM) approach and MR‐Egger regression. In addition, we conducted sensitivity analyses to assess the robustness of MR analyses.

Results

Genetically predicted higher VAT mass is causally associated with a higher risk of NAFLD. The three analysis results of MR were as follows: IVW ( β = 0.665, odds ratio [OR] = 1.944, 95% confidence interval [CI] = 1.482–2.550, p = 1.58e−06], WM ( β = 0.615, OR = 1.849, 95% CI = 1.272–2.689, p = 1.29e−03), and MR‐Egger ( β = 1.250, OR = 3.490, 95% CI = 1.522–7.998, p = 3.52e−03). In the sensitivity analysis, the data showed heterogeneity ( p < 0.05) but no pleiotropy ( p = 0.145).

Conclusion

This study provided genetic evidence that higher VAT mass causally associated with a higher risk of NAFLD. The amount of VAT could be reduced using a therapeutic strategy for managing NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genome-Wide Association StudyNon-alcoholic Fatty Liver DiseaseHumansIntra-Abdominal FatMendelian Randomization AnalysisOdds Ratio

Stichwörter der Autor:innen

Mendelian randomizationnonalcoholic fatty liver diseasevisceral adipose tissue

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, China.

ORCID-Profile: Min Tao, Lili Zhang

Zitieren

APA

Tao, M., Zhou, G., Liu, J., He, M., Wang, C., Luo, X., & Zhang, L. (2023). Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study. Clinical Endocrinology, 99(4), 370-377. https://doi.org/10.1111/cen.14953

Vancouver

Tao M, Zhou G, Liu J, He M, Wang C, Luo X, et al. Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study. Clinical Endocrinology. 2023;99(4):370-377. doi:10.1111/cen.14953

BibTeX
@article{Tao2023,
  author = {Tao, Min and Zhou, Guanghong and Liu, Jing and He, Miao and Wang, Cong and Luo, Xie and Zhang, Lili},
  title = {Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study},
  journal = {Clinical Endocrinology},
  year = {2023},
  volume = {99},
  number = {4},
  pages = {370--377},
  doi = {10.1111/cen.14953}
}
Kostenlos starten →